|
|
2025's Stock Market Performance
|
|
2025's Stock Market Performance
|
2025's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2025.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 10/01/26.
2025's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2025 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 10/01/26.
2025's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2025 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 10/01/26.
2025's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2025 with the market capitalization, trading under 50 million U.S. dollars, as of 10/01/26.
Who are the 2025's Stock Market Winners?
PGY
+117.03%
|
|
|
Pagaya Technologies Ltd
Miscellaneous Financial Services Industry
PGY
+117.03%
Pagaya Technologies Ltd is a financial technology company that specializes in asset management and investment solutions. Their business model leverages artificial intelligence and data analytics to identify investment opportunities in alternative lending markets. By utilizing these technologies, Pagaya aims to deliver superior risk-adjusted returns to its clients.
|
IVA
+117.29%
|
|
|
Inventiva S a
Major Pharmaceutical Preparations Industry
IVA
+117.29%
Inventiva S is a company that operates using a specific business model.
|
CENX
+118.52%
|
|
|
Century Aluminum Company
Aluminum Industry
CENX
+118.52%
Century Aluminum Company*s business model revolves around the production and sale of primary aluminum, primarily focusing on the manufacturing of high-quality aluminum products.
|
AGX
+118.62%
|
|
|
Argan Inc
Construction Services Industry
AGX
+118.62%
Argan Inc*s business model focuses on providing construction and engineering services primarily to the power and renewable energy industries.
|
URGN
+118.88%
|
|
|
Urogen Pharma Ltd
Major Pharmaceutical Preparations Industry
URGN
+118.88%
Urogen Pharma Ltd is a pharmaceutical company that specializes in developing and commercializing innovative therapies for urological and oncological conditions. Their business model revolves around conducting extensive research and development to create novel therapies, obtaining necessary regulatory approvals, and strategically partnering with healthcare providers and other stakeholders to market and distribute their products globally. By focusing on addressing unmet medical needs in the urology field, Urogen Pharma aims to improve patient outcomes and establish a strong presence in the market.
|
PPTA
+119.10%
|
|
|
Perpetua Resources Corp
Metal Mining Industry
PPTA
+119.10%
Perpetua Resources Corp is a mining company that focuses on the exploration and development of precious and base metal projects. Their business model revolves around identifying mineral deposits, extracting and processing these resources, and ultimately selling them in the market.
|
ALNT
+119.48%
|
|
|
Allient Inc
IT Infrastructure Industry
ALNT
+119.48%
Allient Inc operates as a data and analytics consulting firm, offering services to businesses seeking to improve their decision-making capabilities through the utilization of data-driven strategies. They provide custom solutions tailored to client needs, leveraging their expertise in data analysis, technology integration, and predictive modeling.
|
PPLT
+120.39%
|
|
|
Abrdn Platinum Etf Trust
Exchange Traded Funds Etf Industry
PPLT
+120.39%
Abrdn Platinum ETF Trust is an investment vehicle that operates by pooling money from various investors and investing it in a diversified portfolio of platinum-related assets. The trust aims to generate returns by capitalizing on the performance and fluctuations in the platinum market. Investors can gain exposure to platinum through the trust*s shares, which are traded on stock exchanges.
|
GLUE
+120.53%
|
|
|
Monte Rosa Therapeutics Inc
Biotechnology & Pharmaceuticals Industry
GLUE
+120.53%
Monte Rosa Therapeutics Inc operates under a specific business model that focuses on a unique approach in the field of therapeutics.
|
ZURA
+122.98%
|
|
|
Zura Bio Limited
Biotechnology & Pharmaceuticals Industry
ZURA
+122.98%
Zura Bio Limited operates on a business model focused on developing and commercializing innovative bio-based solutions.
|
MUX
+124.09%
|
|
|
Mcewen Inc
Metal Mining Industry
MUX
+124.09%
Mcewen Mining Inc*s business model focuses on the exploration, development, and production of precious metals such as gold and silver.
|
SII
+125.21%
|
|
|
Sprott Inc
Miscellaneous Financial Services Industry
SII
+125.21%
The company manages investment products specializing in precious metals and critical materials.
|
PHAT
+126.33%
|
|
|
Phathom Pharmaceuticals Inc
Major Pharmaceutical Preparations Industry
PHAT
+126.33%
Phathom Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing treatments for gastrointestinal diseases. Their business model involves advancing their pipeline of drug candidates through research and development, and seeking regulatory approval for commercialization. By strategically targeting unmet medical needs in the gastrointestinal space, Phathom Pharmaceuticals aims to provide innovative solutions to improve patient outcomes.
|
XERS
+126.88%
|
|
|
Xeris Biopharma Holdings Inc
Major Pharmaceutical Preparations Industry
XERS
+126.88%
Xeris Biopharma Holdings Inc*s business model focuses on developing and commercializing innovative therapeutics for various medical conditions.
|
EYPT
+127.52%
|
|
|
Eyepoint Inc
Laboratory Analytical Instruments Industry
EYPT
+127.52%
Eyepoint Pharmaceuticals Inc is a pharmaceutical company that operates on a specialty business model focused on advancing ophthalmic therapies. They develop and commercialize innovative treatments using their proprietary drug delivery technology, allowing for sustained release of drugs to the eye. By leveraging their expertise in ophthalmology and controlled release technology, Eyepoint aims to improve patient outcomes and address unmet medical needs in eye care.
|
YQ
+128.03%
|
|
|
17 Education and Technology Group Inc
Educational Services Industry
YQ
+128.03%
17 Education and Technology Group Inc*s business model revolves around developing and providing educational products and services utilizing technology.
|
|
214.36 %
PREV.